Back to calendar
ARS Pharmaceuticals, Inc. (SPRY) Earnings
SPRY reports earnings on Wednesday, August 12, 2026
earnings report
August 12, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.48
Actual EPS: $-0.61
EPS surprise: -18.22%
Company overview
Market Cap$560.1M
PriceUSD 5.64
EPS (TTM)-2.00
52-week high18.50
52-week low5.62
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees163